WI Harper Group agreed to partner with two other investment firms to fund startups that have US-China cross-border promise. In life science, the companies will look for cross-border opportunities in healthcare IT, medical devices and biotech, supporting China’s goal of improving its technology infrastructure. The two other investment firms are Luxin Venture Capital Group and Shandong Leader Equity Investment Fund. No specific fundraising targets were disclosed.